Additional information
| Active substance | Avanafil |
|---|---|
| Trade name | Stendra, Spedra |
| Side effects | Headache, flushing, nasal congestion, back pain, nasal congestion, dizziness, and gastrointestinal disturbances |
| Effects | Helps achieve and maintain an erection |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 100 mg taken as needed about 30 minutes before sexual activity, adjusted as necessary |
| Half-life | Approximately 5 hours |
| Main action | Increases blood flow to particular areas of the body |
| Substance class | PDE5 inhibitor |
| Formula | C23H26ClN7O3 |
| Chemical name | 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Blood pressure | Can cause a slight reduction in blood pressure |
| WAREHOUSE | International Warehouse 1 |
| Also known as | TA-1790 |
| Lab Test | Not specifically listed |
| Aromatization | No |
| Hepatotoxicity | No |
| HBR | Possible |
| Water Retention | No |
| Acne | No |
| Dosage | Men 50-200 mg/day |
| Classification | PDE5 inhibitor |
| Active Half-Life | 9-10 hours |
| Use in sports | Not typically used in sports |
| Manufacturer | Sunrise Remedies |
